Medical staff at the temporary screening clinic in Seoul Station Plaza are guiding citizens who visited for testing of the novel coronavirus infection (COVID-19). [Image source=Yonhap News]

Medical staff at the temporary screening clinic in Seoul Station Plaza are guiding citizens who visited for testing of the novel coronavirus infection (COVID-19). [Image source=Yonhap News]

View original image

[Asia Economy Reporter Chunhee Lee] The fourth case of pediatric and adolescent multisystem inflammatory syndrome (MIS-C) has occurred in South Korea.


The Central Disease Control Headquarters (CDCH) announced on the 10th, "The fourth case of COVID-19-related pediatric and adolescent multisystem inflammatory syndrome has been confirmed in South Korea."


The fourth domestic patient is a 15-year-old male adolescent. He was infected through contact with a confirmed COVID-19 patient. He was admitted to a residential treatment center for two weeks in December last year and was discharged.


However, after that, symptoms such as fever, diarrhea, and headache appeared, and he was hospitalized at a medical institution on January 23. His symptoms improved, and he recovered and was discharged on the 3rd of last month.


The health authorities received a report on January 27 and conducted an epidemiological investigation and laboratory tests. After expert review, it was determined to be consistent with multisystem inflammatory syndrome.


This case is the first pediatric and adolescent multisystem inflammatory syndrome case confirmed since the third case was identified in October last year. Since October last year, a total of five suspected cases have been additionally reported, but only this case was evaluated as consistent with pediatric and adolescent multisystem inflammatory syndrome.



Pediatric and adolescent multisystem inflammatory syndrome, also known as the "children's mysterious disease," has been reported as a unique case mainly among children and adolescents in Europe, the United States, and other regions since April last year. It is a systemic inflammatory response that appears weeks after COVID-19 infection with symptoms such as fever and rash, and in severe cases, it can cause multiple organ dysfunction and even death.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing